Neurology
Physicians often bypass cognition, depression screening in MS
REPORTING FROM ACTRIMS FORUM 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – A new study ...
Study identifies characteristics that may constitute the MS prodrome
REPORTING FROM ACTRIMS FORUM 2018 San Diego (FRONTLINE MEDICAL NEWS) – Compared with controls, ...
Nearly half of MS patients treated by primary docs miss out on meds
REPORTING FROM ACTRIMS FORUM 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – Multiple sclerosis (MS) ...
Many prescriptions for older epilepsy patients have potential to interact
FROM EPILEPSIA A substantial portion of older adults with epilepsy who are on Medicare ...
On-label stent use looks safe in intracranial atherosclerotic disease
REPORTING FROM ISC 2018 LOS ANGELES (FRONTLINE MEDICAL NEWS) – A postmarketing study of ...
Imaging methods for stroke thrombectomy eligibility yield similar results
REPORTING FROM ISC 2018 LOS ANGELES (FRONTLINE MEDICAL NEWS) – The benefits of mechanical ...
MS may be a transmissible protein misfolding disorder, study suggests
REPORTING FROM ACTRIMS FORUM 2018 SAN DIEGO (FRONTLINE MEDICAL NEWS) – Multiple sclerosis appears ...
No improvement in sight for Alzheimer’s drug development
Another one bites the dust. Yet another investigational agent joins intepirdine, verubecestat, solanezumab, bapineuzumab, ...
Ticagrelor may be superior to clopidogrel in poor metabolizers
REPORTING FROM ISC 2018 LOS ANGELES (FRONTLINE MEDICAL NEWS) – In patients who had ...
Tenecteplase surpasses alteplase for thrombolysing acute ischemic stroke
REPORTING FROM ISC 2018 LOS ANGELES (FRONTLINE MEDICAL NEWS) – Thrombolysis with tenecteplase beat ...
Rituximab fails to eliminate meningeal inflammation in progressive MS
FROM ACTRIMS FORUM 2018 Researchers are heading back to the drawing board after a ...
Fingolimod cuts pediatric MS relapse rate more than interferon beta-1a
FROM ACTRIMS FORUM 2018 Pediatric patients with relapsing remitting multiple sclerosis (MS) had fewer ...
Study finds rising use of newer DMTs in pediatric-onset MS
FROM ACTRIMS FORUM 2018 Newer disease-modifying therapies are often used in patients with pediatric-onset ...